Tuesday 6 February 2018

Press Release: BioLargo Completes Study of Breakthrough Water Treatment Technology for Poultry Process Water and Municipal Wastewater Treatment

Westminster CA – February 6, 2018 – BioLargo Inc. (OTCQB: BLGO) (the “Company”), an innovator of sustainable science and technology and full-service environmental engineering company, announced today the completion of a study that demonstrates the effectiveness of its Advanced Oxidation System (“AOS”) water treatment platform for treatment of poultry wastewater and municipal tertiary wastewater. The study was partially funded by the Metropolitan Water District (“MWD”) of Southern California’s Innovative Conservation Program (“ICP” - http://mwdh2o.com/ICP). A report of the study’s conclusions can be found online at MWD’s ICP website, at http://www.bewaterwise.com/ICP_projects.shtml.
To highlight the report, the AOS was shown to:
  • To be at least 50% more energy-efficient in comparison to incumbent technologies (U.V.  and Ozone);
  • Be forecasted to involve far less maintenance cost than chlorination; and
  • Could present an effective and cost-efficient alternative to market-available tertiary treatment technologies, and stands to afford major water and costs savings to the Californian municipal wastewater market
These results complement the AOS’s prior proof-of-claim results that prove the AOS can:
  • Completely remove polyaromatic hydrocarbons;
  • Inactivate 6 logs of bacterial pathogens (Salmonella enterica and Escherichia coli);
  • Inactivate 4 logs of virus surrogate; and
  • Remove naphthenic acids (up to 80% in single pass)
BioLargo President and Chief Executive Officer Dennis Calvert commented, “This report demonstrates the enormous cost and water recycling benefits the AOS will have for end-users. We recently acquired a world-class team of engineers (www.BioLargoEngineering.com), to provide problem-solving solutions for clients and support the scale-up and commercial preparation for the AOS already underway. We are also evaluating a number of strategic alliance, public funding opportunities, pilots and customer opportunities for our AOS technology.”

About BioLargo, Inc.
BioLargo, Inc. is an innovator of sustainable science and technology, and full-service environmental engineering company that makes life better by delivering world-class products and services across a broad range of industries, with a drive to deliver clean water, clean air and advanced wound care. More information can be found about the company at www.BioLargo.com. Its engineering division (www.BioLargoEngineering.com) features an exceptional team of experienced specialists dedicated to integrity, reliability, safety, and environmental stewardship. It water division (www.BioLargoWater.com) showcases its emerging technology, the Advanced Oxidation System “AOS”, an award-winning product, having been awarded more than 55 research grants and counting, specifically designed to eliminate common, troublesome, and dangerous contaminants in water in a fraction of the time and cost of current technologies. Its odor division features sustainable odor elimination products including its CupriDyne Clean (www.CupriDyne.com) Industrial Odor Eliminator, a product currently serving the leading solid waste handling and wastewater treatment companies as well as any industry that that contends with malodors, VOC’s or similar air quality related problems. Its personal care product division features products in the pet, equine, military supply and consumer markets, and include the Nature’s Best Solution® and Deodorall® brands (www.OdorNoMore.com). Its medical division (www.ClyraMedical.com) focuses on advanced wound care management, featuring effective and gentle solutions for chronic infected wounds and other uses to promote infection control and regenerative tissue therapy. BioLargo also owns a 50% interest in the Isan System, a fully automated iodine dosing system being commercialized under a license to Clarion Water, Inc (www.ClarionWater.com).  

Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K.

Company Contact
Dennis Calvert
President and CEO
BioLargo, Inc.
949-643-9540 x2

Thursday 1 February 2018

Company Progress Report - Dennis Calvert Interviewed by Uptick Newswire

BioLargo CEO Dennis Calvert returned to Uptick Newswire Stock Day Podcast with Everett Jolly today to deliver an important and welcome update on the company's progress in its multiple advancing businesses.

BioLargo has seen numerous successes in recent weeks, both in new contracts and sales, and in crucial developments for its disruptive water treatment platform, the Advanced Oxidation System (AOS):

Odor-No-More/CupriDyne Clean Industrial Odor Control:
  • Sales are accelerating
  • Winning new customers constantly, and spreading across the country rapidly
  • Once a customer tries CupriDyne Clean, they never go back to our competitors. Our product provides vastly superior performance, at a significant cost savings
  • Expanding uses! Customers using CupriDyne Clean to control VOCs
BioLargo Engineering (BLEST):
  • Roughly 10 new customer accounts!
  • Opportunities and invitations rapidly accelerating - team's professional credibility paying dividends
  • Internal work is accelerating AOS development
Clyra Medical:
  • Quietness of Clyra Medical is due to impending FDA 510(k) decision on our products
  • Average FDA 510(k) application takes 177 days. We are only just past 100 days, and we are confident about the application
  • Huge opportunity, simply waiting for regulatory approval
  • Patience is required
Advanced Oxidation System (AOS):
  • Our science is proven
  • Development is progressing for pilot prototype of AOS - being advanced by our new engineering unit
  • Recently attended Canadian government-sponsored trade mission in China where there was big interest in AOS for pilots and trials in China
  • China is flush with cash, has significant water issues and is hunting for solutions like the AOS.
  • Engineering team is developing a full scale-up strategy and plan to create a full-scale AOS, which will be implemented soon
  • AOS now been demonstrated potentially disruptive to important and huge water treatment segments like:
    • Storm water treatment
    • Removal of selenium
    • Pharmaceuticals
    • Protozoan parasites (eg. Cryptosporidium)
    • Viruses
  • Proven the AOS capable of treating highly contaminated real-world water sources like:
    • Secondary and tertiary municipal wastewater
    • Poultry processing wastewater
    • Contaminated river water